First Eagle Investment Management LLC decreased its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 1.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,719,950 shares of the company’s stock after selling 173,144 shares during the period. Colgate-Palmolive comprises about 1.8% of First Eagle Investment Management LLC’s investment portfolio, making the stock its 19th biggest holding. First Eagle Investment Management LLC’s holdings in Colgate-Palmolive were worth $792,731,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Chicago Partners Investment Group LLC increased its holdings in shares of Colgate-Palmolive by 16.2% in the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock worth $591,000 after purchasing an additional 943 shares in the last quarter. Peak Financial Advisors LLC purchased a new position in shares of Colgate-Palmolive in the 4th quarter worth $1,315,000. Fiduciary Alliance LLC purchased a new position in shares of Colgate-Palmolive in the 4th quarter worth $4,066,000. Impact Partnership Wealth LLC purchased a new position in shares of Colgate-Palmolive in the 4th quarter worth $803,000. Finally, Barclays PLC boosted its stake in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after buying an additional 2,132,747 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Price Performance
NYSE:CL opened at $90.41 on Friday. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The business’s 50-day simple moving average is $89.03 and its two-hundred day simple moving average is $94.93. The stock has a market cap of $73.37 billion, a PE ratio of 25.69, a P/E/G ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on the company. Piper Sandler dropped their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. TD Cowen dropped their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Barclays dropped their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. JPMorgan Chase & Co. dropped their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. Finally, StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $101.61.
View Our Latest Report on Colgate-Palmolive
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Undervalued Stocks You Can Buy at a Discount Now
- The Significance of Brokerage Rankings in Stock Selection
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- How to Most Effectively Use the MarketBeat Earnings Screener
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.